X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (31) 31
humans (25) 25
oncology (23) 23
lung cancer (22) 22
male (18) 18
aged (17) 17
female (17) 17
middle aged (14) 14
lung neoplasms - drug therapy (12) 12
lung neoplasms - pathology (12) 12
chemotherapy (10) 10
respiratory system (10) 10
carcinoma, non-small-cell lung - drug therapy (9) 9
cancer (8) 8
docetaxel (8) 8
medicine, general & internal (8) 8
gefitinib (7) 7
non-small cell lung cancer (7) 7
research (7) 7
bronchoscopy (6) 6
care and treatment (6) 6
erlotinib (6) 6
hematology, oncology and palliative medicine (6) 6
lung cancer, non-small cell (6) 6
lung neoplasms - genetics (6) 6
pulmonary/respiratory (6) 6
retrospective studies (6) 6
tomography, x-ray computed (6) 6
treatment outcome (6) 6
adenocarcinoma (5) 5
adult (5) 5
aged, 80 and over (5) 5
analysis (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
carboplatin (5) 5
carcinoma, non-small-cell lung - pathology (5) 5
case report (5) 5
crizotinib (5) 5
mutation (5) 5
survival (5) 5
tumors (5) 5
tyrosine (5) 5
acquired-resistance (4) 4
animals (4) 4
bronchoalveolar lavage (4) 4
carcinoma, non-small-cell lung - genetics (4) 4
carcinoma, non-small-cell lung - mortality (4) 4
cell lung-cancer (4) 4
genetic aspects (4) 4
kaplan-meier estimate (4) 4
lung neoplasms - complications (4) 4
lung neoplasms - mortality (4) 4
metastases (4) 4
mice, inbred balb c (4) 4
nivolumab (4) 4
non-small cell lung carcinoma (4) 4
non-small-cell lung cancer (4) 4
receptor, epidermal growth factor - genetics (4) 4
therapy (4) 4
usage (4) 4
1st-line treatment (3) 3
adenocarcinoma - complications (3) 3
adenocarcinoma - pathology (3) 3
adenocarcinoma of lung (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
bevacizumab (3) 3
biopsy (3) 3
bronchoscopy - methods (3) 3
cancer therapies (3) 3
cell biology (3) 3
cell line, tumor (3) 3
combination (3) 3
diagnosis (3) 3
endobronchial ultrasonography with a guide sheath (3) 3
epidermal growth factor (3) 3
fluoroscopy (3) 3
gene mutations (3) 3
immunotherapy (3) 3
internal medicine (3) 3
interstitial lung disease (3) 3
lung - pathology (3) 3
lung cancer, small cell (3) 3
lung neoplasms - diagnosis (3) 3
lung-cancer (3) 3
medical research (3) 3
metastasis (3) 3
multicenter (3) 3
neoplasm staging (3) 3
oncology, experimental (3) 3
open-label (3) 3
osimertinib (3) 3
paclitaxel (3) 3
prognosis (3) 3
protein-tyrosine kinase (3) 3
respiratory tract diseases (3) 3
18f-fdg pet/ct (2) 2
adenocarcinoma - drug therapy (2) 2
adenocarcinoma - genetics (2) 2
afatinib (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 663 - 671
Journal Article
Journal of Thoracic Disease, ISSN 2072-1439, 05/2019, Volume 11, Issue S9, pp. S1289 - S1291
Journal Article
BMC Cancer, ISSN 1471-2407, 10/2018, Volume 18, Issue 1, pp. 946 - 946
Journal Article
Current cancer drug targets, 12/2018
Lung cancer is the leading cause of cancer death worldwide. Molecular targeted therapy has greatly advanced the field of treatment for non-small cell lung... 
Journal Article
INTERNAL MEDICINE, ISSN 0918-2918, 2019, Volume 58, Issue 10, pp. 1467 - 1471
Journal Article
Cancer Science, ISSN 1347-9032, 07/2017, Volume 108, Issue 7, pp. 1368 - 1377
Journal Article
Anticancer Research, ISSN 0250-7005, 02/2019, Volume 39, Issue 2, pp. 815 - 825
Journal Article
Respiratory Research, ISSN 1465-9921, 11/2016, Volume 17, Issue 1, pp. 146 - 146
Journal Article
Respirology Case Reports, ISSN 2051-3380, 04/2019, Volume 7, Issue 3, pp. e00404 - n/a
We present the case of a 70‐year‐old man with stage IV lung adenocarcinoma. He was treated with pembrolizumab, a programmed cell death‐1 (PD‐1) inhibitor, as a... 
pembrolizumab | pericardial effusion | cardial tamponade | Lung adenocarcinoma | Lung cancer | Clinical outcomes | Inhibitor drugs
Journal Article
Internal Medicine, ISSN 0918-2918, 2020
A 51-year-old man underwent second-line treatment for non-small-cell lung cancer (NSCLC) with the immune checkpoint inhibitor (ICI) pembrolizumab. On day 2... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.